"10.1371_journal.pone.0033925","plos one","2012-03-21T00:00:00Z","Norbert Donhauser; Kathrin Pritschet; Martin Helm; Thomas Harrer; Philipp Schuster; Moritz Ries; Georg Bischof; Jörg Vollmer; Sigrun Smola; Barbara Schmidt; for the German Competence Network HIV/AIDS","Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Praxis Dr. G. Abelein/Dr. M. Helm, Nürnberg, Germany; Department for Internal Medicine III, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Pfizer Oligonucleotide Therapeutics Unit, Coley Pharmaceutical GmbH, Düsseldorf, Germany; Institute of Virology, Saarland University, Homburg/Saar, Germany","Conceived and designed the experiments: ND KP PS MR SS BS. Performed the experiments: ND KP PS MR GB. Analyzed the data: ND BS. Contributed reagents/materials/analysis tools: MH TH JV SS. Wrote the paper: ND TH SS BS. Primary author: BS.","Jörg Vollmer has a potential conflict of interest as he is an employee of Pfizer and provided the CpG oligodeoxynucleotides used in the study. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Norbert Donhauser","ND",11,TRUE,6,5,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
